Navigation Links
Idenix Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference

CAMBRIDGE, Mass., May 12 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix management will present a corporate overview at the Rodman & Renshaw 5th Annual Global Healthcare Conference on Tuesday, May 20, 2008 at 12:00 p.m. CEST at Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco.

The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at Please log in approximately 5-10 minutes before each event to ensure a timely connection. The archived replays will be available on the Idenix website for two weeks following the conference.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus and HIV. For further information about Idenix, please refer to

Idenix Pharmaceutical Contact:

Ron Renaud (617) 995-9800

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
2. Idenix to Host Conference Call Discussing Third Quarter 2007 Financial Results
3. Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
4. Idenix to Host Conference Call Discussing Fourth Quarter 2007 Financial Results
5. Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
6. Idenix Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
7. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
8. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
10. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
Post Your Comments:
(Date:11/23/2015)... ... November 23, 2015 , ... Shimadzu Corporation announces that it ... Unified Chromatography system. The award from R&D magazine recognizes Shimadzu’s Nexera UC system ... in the analytical and testing category. R&D Magazine chose the Nexera UC system ...
(Date:11/23/2015)... CAMBRIDGE, England and PISCATAWAY, ... -- Cambridge Crystallographic Data Centre ... of the Cambridge Structural Database (CSD) and the ... suites for researchers worldwide: CSD-Discovery to support the ... of crystalline materials, and CSD-Enterprise, the complete set ...
(Date:11/23/2015)... WASHINGTON , Nov. 23, 2015 ... research firm to exclusively serve the ... of its global strategic report, "Mesenchymal ... Published November 2015, it presents 250 ... mesenchymal stem cell (MSC) industry. ...
(Date:11/23/2015)... 2015 Research and Markets ( ) has ... Service Type, Product/Technology, Application and Geography - Global forecast to ... --> --> The overall service laboratory market ... to USD 5.45 Billion by 2020, at a CAGR of ... --> The market in APAC is expected ...
Breaking Biology Technology:
(Date:11/18/2015)... 2015 --> ... market report titled  Gesture Recognition Market - Global Industry ... 2021. According to the report, the global gesture recognition market was valued ... reach US$29.1 bn by 2021, at a CAGR of ... America dominated the global gesture recognition market ...
(Date:11/16/2015)... , Nov 16, 2015  Synaptics Inc. ... human interface solutions, today announced expansion of its ... ™ touch controller and display driver integration ... of smartphones. These new TDDI products add to ... (HD resolution), TD4302 (WQHD resolution), and TD4322 (FHD ...
(Date:11/10/2015)... 2015  In this report, the biomarkers ... product, type, application, disease indication, and geography. ... are consumables, services, software. The type segments ... efficacy biomarkers, and validation biomarkers. The applications ... development, drug discovery and development, personalized medicine, ...
Breaking Biology News(10 mins):